New drug firsekibart tested to stop painful gout attacks

NCT ID NCT07625514

Not yet recruiting Disease control Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will follow 264 adults with frequent gout flares to see how often attacks return within 24 weeks after starting firsekibart. Researchers will also track side effects and how quickly flares resolve. The goal is to understand if this medication helps control gout in everyday medical practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE GOUTY ARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gout

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GOUT FLARE

Contacts and locations

Locations

Changxin People's Hospital

Huzhou, China
Fuzhou University Affiliated Provincial Hospital

Fuzhou, China
Jinhua Municipal Central Hospital

Jinhua, China
Ningbo Medical Center Lihuili Hospital

Ningbo, China
The First People's Hospital of Wenlin

Wenzhou, China
The Second Affiliated Hospital Zhejiang University School of Medicine

Hangzhou, China
The Second Affiliated Hospital of Wenzhou Medical University

Wenzhou, China
The Second Affiliated Hospital of Zhejiang Chinese Medical University

Hangzhou, China
Tongde Hospital of Zhejiang Province

Hangzhou, China
Zhejiang Hospital

Hangzhou, China
Zhejiang Provincial People's Hospital

Hangzhou, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.